Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alice C Wei

Showing results (131-140 of 172) with videos related to

Pageof 18
Sort By:
Annals of Surgical Oncology|June 18, 2021
Added Value of Radiotherapy Following Neoadjuvant FOLFIRINOX for Resectable and Borderline Resectable Pancreatic Cancer: A Systematic Review and Meta-AnalysisQuisette P Janssen, Jacob L van Dam, Isabelle G Kivits, et al.
Cancer Medicine|April 16, 2023
Hepatic disease control in patients with intrahepatic cholangiocarcinoma correlates with overall survivalKevin C Soares, Joshua S Jolissaint, Sarah M McIntyre, et al.
Annals of Surgical Oncology|April 16, 2026
Eligibility for Liver Transplantation in Patients with Intrahepatic CholangiocarcinomaLauren E Schleimer, Merve Rousian, Remo Alessandris, et al.
Annals of Surgery|May 25, 2026
Pancreas Cancer Risk During Intraductal Papillary Mucinous Neoplasm Surveillance - A SEER-Based ComparisonAnkur P Choubey, Joanne F Chou, Remo Alessandris, et al.
Journal of Vascular and Interventional Radiology : JVIR|November 7, 2025
Safety and Feasibility of Intra-Arterial Treatment of Pancreatic Cancer Using an Emulsion of Ethiodized Oil plus Bumetanide in an Oncopig ModelHooman Yarmohammadi, Sam Y Son, Aaron W P Maxwell, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|November 26, 2018
Neoadjuvant therapy and major arterial resection for potentially reconstructable arterial involvement by stage 3 adenocarcinoma of the pancreasBenjamin P T Loveday, Nathan Zilbert, Pablo E Serrano, et al.
CA: a Cancer Journal for Clinicians|April 29, 2024
Critical updates in neuroendocrine tumors: Version 9 American Joint Committee on Cancer staging system for gastroenteropancreatic neuroendocrine tumorsAman Chauhan, Kelley Chan, Thorvardur R Halfdanarson, et al.
JAMA Network Open|December 5, 2023
Liver Metastases and Immune Checkpoint Inhibitor Efficacy in Patients With Refractory Metastatic Colorectal Cancer: A Secondary Analysis of a Randomized Clinical TrialEric X Chen, Jonathan M Loree, Emma Titmuss, et al.
The Lancet. Gastroenterology & Hepatology|February 5, 2018
Napabucasin versus placebo in refractory advanced colorectal cancer: a randomised phase 3 trialDerek J Jonker, Louise Nott, Takayuki Yoshino, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|July 13, 2022
Neoadjuvant Radiotherapy After (m)FOLFIRINOX for Borderline Resectable Pancreatic Adenocarcinoma: A TAPS Consortium StudyQuisette P Janssen, Jacob L van Dam, Laura R Prakash, et al.
Pageof 18

Showing results (131-140 of 172) with videos related to

Sort By:
Pageof 18
Annals of Surgical Oncology|June 18, 2021
Added Value of Radiotherapy Following Neoadjuvant FOLFIRINOX for Resectable and Borderline Resectable Pancreatic Cancer: A Systematic Review and Meta-AnalysisQuisette P Janssen, Jacob L van Dam, Isabelle G Kivits, et al.
Cancer Medicine|April 16, 2023
Hepatic disease control in patients with intrahepatic cholangiocarcinoma correlates with overall survivalKevin C Soares, Joshua S Jolissaint, Sarah M McIntyre, et al.
Annals of Surgical Oncology|April 16, 2026
Eligibility for Liver Transplantation in Patients with Intrahepatic CholangiocarcinomaLauren E Schleimer, Merve Rousian, Remo Alessandris, et al.
Annals of Surgery|May 25, 2026
Pancreas Cancer Risk During Intraductal Papillary Mucinous Neoplasm Surveillance - A SEER-Based ComparisonAnkur P Choubey, Joanne F Chou, Remo Alessandris, et al.
Journal of Vascular and Interventional Radiology : JVIR|November 7, 2025
Safety and Feasibility of Intra-Arterial Treatment of Pancreatic Cancer Using an Emulsion of Ethiodized Oil plus Bumetanide in an Oncopig ModelHooman Yarmohammadi, Sam Y Son, Aaron W P Maxwell, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|November 26, 2018
Neoadjuvant therapy and major arterial resection for potentially reconstructable arterial involvement by stage 3 adenocarcinoma of the pancreasBenjamin P T Loveday, Nathan Zilbert, Pablo E Serrano, et al.
CA: a Cancer Journal for Clinicians|April 29, 2024
Critical updates in neuroendocrine tumors: Version 9 American Joint Committee on Cancer staging system for gastroenteropancreatic neuroendocrine tumorsAman Chauhan, Kelley Chan, Thorvardur R Halfdanarson, et al.
JAMA Network Open|December 5, 2023
Liver Metastases and Immune Checkpoint Inhibitor Efficacy in Patients With Refractory Metastatic Colorectal Cancer: A Secondary Analysis of a Randomized Clinical TrialEric X Chen, Jonathan M Loree, Emma Titmuss, et al.
The Lancet. Gastroenterology & Hepatology|February 5, 2018
Napabucasin versus placebo in refractory advanced colorectal cancer: a randomised phase 3 trialDerek J Jonker, Louise Nott, Takayuki Yoshino, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|July 13, 2022
Neoadjuvant Radiotherapy After (m)FOLFIRINOX for Borderline Resectable Pancreatic Adenocarcinoma: A TAPS Consortium StudyQuisette P Janssen, Jacob L van Dam, Laura R Prakash, et al.
Pageof 18